Variant report

Variant	esv3357703
Chromosome Location	chr6:163147387-163149935
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:163148702-163148902	K562	blood:	n/a	n/a
2	ARID3A	chr6:163148619-163149118	HepG2	liver:	n/a	n/a
3	ATF1	chr6:163148753-163149159	K562	blood:	n/a	n/a
4	ATF2	chr6:163148704-163149149	GM12878	blood:	n/a	chr6:163148957-163148968
5	ATF2	chr6:163148711-163149191	H1-hESC	embryonic stem cell:	n/a	chr6:163148957-163148968
6	ATF2	chr6:163148705-163149166	GM12878	blood:	n/a	chr6:163148957-163148968
7	ATF2	chr6:163148726-163149178	H1-hESC	embryonic stem cell:	n/a	chr6:163148957-163148968
8	ATF3	chr6:163148710-163149085	K562	blood:	n/a	chr6:163148957-163148968 chr6:163148970-163148979 chr6:163148959-163148967 chr6:163148957-163148970 chr6:163148955-163148970 chr6:163148957-163148968 chr6:163148959-163148970 chr6:163148958-163148978 chr6:163148956-163148969 chr6:163148848-163148857 chr6:163148959-163148969
9	ATF3	chr6:163148498-163149119	HepG2	liver:	n/a	chr6:163148957-163148968 chr6:163148970-163148979 chr6:163148959-163148967 chr6:163148957-163148970 chr6:163148955-163148970 chr6:163148957-163148968 chr6:163148959-163148970 chr6:163148958-163148978 chr6:163148956-163148969 chr6:163148848-163148857 chr6:163148959-163148969
10	ATF3	chr6:163148789-163149068	H1-hESC	embryonic stem cell:	n/a	chr6:163148957-163148968 chr6:163148970-163148979 chr6:163148959-163148967 chr6:163148957-163148970 chr6:163148955-163148970 chr6:163148957-163148968 chr6:163148959-163148970 chr6:163148958-163148978 chr6:163148956-163148969 chr6:163148848-163148857 chr6:163148959-163148969
11	ATF3	chr6:163148729-163149180	H1-hESC	embryonic stem cell:	n/a	chr6:163148957-163148968 chr6:163148970-163148979 chr6:163148959-163148967 chr6:163148957-163148970 chr6:163148955-163148970 chr6:163148957-163148968 chr6:163148959-163148970 chr6:163148958-163148978 chr6:163148956-163148969 chr6:163148848-163148857 chr6:163148959-163148969
12	ATF3	chr6:163148738-163149179	K562	blood:	n/a	chr6:163148957-163148968 chr6:163148970-163148979 chr6:163148959-163148967 chr6:163148957-163148970 chr6:163148955-163148970 chr6:163148957-163148968 chr6:163148959-163148970 chr6:163148958-163148978 chr6:163148956-163148969 chr6:163148848-163148857 chr6:163148959-163148969
13	BACH1	chr6:163148603-163148838	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr6:163149073-163149266	K562	blood:	n/a	n/a
15	BCLAF1	chr6:163148707-163149054	GM12878	blood:	n/a	chr6:163148747-163148760
16	BHLHE40	chr6:163148582-163149115	K562	blood:	n/a	chr6:163148747-163148763
17	BHLHE40	chr6:163148697-163149088	GM12878	blood:	n/a	chr6:163148747-163148763
18	BHLHE40	chr6:163148554-163149138	HepG2	liver:	n/a	chr6:163148747-163148763
19	BRCA1	chr6:163148845-163149085	Hela-S3	cervix:	n/a	n/a
20	BRCA1	chr6:163148841-163149053	HepG2	liver:	n/a	n/a
21	CBX3	chr6:163148516-163149230	K562	blood:	n/a	n/a
22	CCNT2	chr6:163148390-163149101	K562	blood:	n/a	chr6:163148913-163148922 chr6:163148970-163148979 chr6:163149075-163149084
23	CEBPB	chr6:163148643-163149149	H1-hESC	embryonic stem cell:	n/a	n/a
24	CEBPB	chr6:163148713-163149149	IMR90	lung:	n/a	n/a
25	CEBPB	chr6:163148769-163149119	MCF-7	breast:	n/a	n/a
26	CEBPB	chr6:163148750-163149181	K562	blood:	n/a	n/a
27	CEBPB	chr6:163148788-163149168	A549	lung:	n/a	n/a
28	CEBPB	chr6:163148686-163149168	A549	lung:	n/a	n/a
29	CEBPB	chr6:163148738-163149145	K562	blood:	n/a	n/a
30	CEBPB	chr6:163148771-163149153	HepG2	liver:	n/a	n/a
31	CEBPB	chr6:163148563-163149157	HepG2	liver:	n/a	n/a
32	CEBPB	chr6:163148779-163149062	HepG2	liver:	n/a	n/a
33	CEBPB	chr6:163148769-163149149	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr6:163148800-163149065	K562	blood:	n/a	n/a
35	CEBPB	chr6:163148734-163149200	MCF-7	breast:	n/a	n/a
36	CEBPD	chr6:163148838-163149102	HepG2	liver:	n/a	n/a
37	CEBPD	chr6:163148521-163149131	HepG2	liver:	n/a	n/a
38	CHD1	chr6:163148818-163148888	GM12878	blood:	n/a	n/a
39	CHD2	chr6:163148677-163149145	HepG2	liver:	n/a	chr6:163149073-163149083
40	CHD2	chr6:163148643-163149138	Hela-S3	cervix:	n/a	chr6:163149073-163149083
41	CHD2	chr6:163148657-163149132	K562	blood:	n/a	chr6:163149073-163149083
42	CHD2	chr6:163148700-163149167	H1-hESC	embryonic stem cell:	n/a	chr6:163149073-163149083
43	CHD2	chr6:163148669-163149124	GM12878	blood:	n/a	chr6:163149073-163149083
44	CREB1	chr6:163148668-163149153	A549	lung:	n/a	n/a
45	CREB1	chr6:163148366-163149267	HepG2	liver:	n/a	n/a
46	CREB1	chr6:163148419-163149170	H1-hESC	embryonic stem cell:	n/a	n/a
47	CREB1	chr6:163148576-163149222	H1-hESC	embryonic stem cell:	n/a	n/a
48	CREB1	chr6:163148541-163149251	K562	blood:	n/a	n/a
49	CREB1	chr6:163148616-163149342	K562	blood:	n/a	n/a
50	CREB1	chr6:163148680-163149184	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:163148777-163148827	GM12878	blood:	n/a
2	chr6:163148018-163148068	HEEpiC	esophagus:	n/a
3	chr6:163148290-163148340	PrEC	prostate:	n/a
4	chr6:163148853-163148903	AG04450	lung:	fetal
5	chr6:163149169-163149219	HEK293	kidney:	embryo
6	chr6:163148777-163148827	HRCEpiC	kidney:	n/a
7	chr6:163148290-163148340	ProgFib	skin:	n/a
8	chr6:163148777-163148827	HL-60	blood:	n/a
9	chr6:163148501-163148551	MCF10A-Er-Src	breast:	n/a
10	chr6:163148762-163148812	NHDF-neo	bronchial:	n/a
11	chr6:163149320-163149370	T-47D	breast:	n/a
12	chr6:163147999-163148049	HRE	kidney:	n/a
13	chr6:163149453-163149503	K562	blood:	n/a
14	chr6:163148022-163148072	AG04449	skin:	fetal
15	chr6:163148290-163148340	HCT-116	colon:	n/a
16	chr6:163149320-163149370	SK-N-SH_RA	brain:	n/a
17	chr6:163148022-163148072	GM12878	blood:	n/a
18	chr6:163148290-163148340	AG04449	skin:	fetal
19	chr6:163149453-163149503	HEK293	kidney:	embryo
20	chr6:163149674-163149724	NHBE	bronchial:	n/a
21	chr6:163149167-163149217	SAEC	small airway:	n/a
22	chr6:163148290-163148340	SAEC	small airway:	n/a
23	chr6:163147733-163147783	AoSMC	blood vessel:	n/a
24	chr6:163149320-163149370	U87	brain:	n/a
25	chr6:163148718-163148768	K562	blood:	n/a
26	chr6:163148018-163148068	HCT-116	colon:	n/a
27	chr6:163149169-163149219	T-47D	breast:	n/a
28	chr6:163149167-163149217	HNPCEpiC	eye:	n/a
29	chr6:163147999-163148049	K562	blood:	n/a
30	chr6:163148762-163148812	NHBE	bronchial:	n/a
31	chr6:163149674-163149724	U87	brain:	n/a
32	chr6:163148290-163148340	ovcar-3	ovarian:	n/a
33	chr6:163149453-163149503	AG09309	skin:	n/a
34	chr6:163147733-163147783	ovcar-3	ovarian:	n/a
35	chr6:163147733-163147783	HEEpiC	esophagus:	n/a
36	chr6:163148501-163148551	Caco-2	colon:	n/a
37	chr6:163147999-163148049	PrEC	prostate:	n/a
38	chr6:163147733-163147783	SAEC	small airway:	n/a
39	chr6:163149674-163149724	BJ	skin:	n/a
40	chr6:163148853-163148903	H1-hESC	embryonic stem cell:	embryo
41	chr6:163147999-163148049	GM12891	blood:	n/a
42	chr6:163149320-163149370	CMK	blood:	n/a
43	chr6:163149674-163149724	SKMC	muscle:	n/a
44	chr6:163147999-163148049	A549	lung:	n/a
45	chr6:163149674-163149724	RPTEC	kidney:	n/a
46	chr6:163148853-163148903	HUVEC	blood vessel:	n/a
47	chr6:163149453-163149503	Jurkat	blood:	n/a
48	chr6:163148018-163148068	ProgFib	skin:	n/a
49	chr6:163148777-163148827	GM19239	blood:	n/a
50	chr6:163148777-163148827	NHDF-neo	bronchial:	n/a

Variant related genes	Relation type
PACRG	TF binding region
PARK2	TF binding region
PACRG	CpG island
PARK2	CpG island

Extended variants
information (count: 125 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:125 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527542414	chr6:163147445-163147446	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs559127567	chr6:163147480-163147481	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs552435862	chr6:163147509-163147510	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs556438383	chr6:163147632-163147633	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs7746602	chr6:163147638-163147639	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs574335564	chr6:163147648-163147649	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs142664904	chr6:163147649-163147650	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs368521400	chr6:163147674-163147675	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs540240884	chr6:163147677-163147678	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs560365637	chr6:163147687-163147688	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs532712306	chr6:163147725-163147726	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs545975711	chr6:163147741-163147742	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs184749607	chr6:163147749-163147750	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs531957886	chr6:163147774-163147775	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs531634603	chr6:163147788-163147789	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs568159326	chr6:163147812-163147813	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs527247297	chr6:163147838-163147839	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs78067160	chr6:163147844-163147845	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs187556549	chr6:163147848-163147849	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs150936122	chr6:163147883-163147884	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs539780289	chr6:163147891-163147892	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs556373083	chr6:163147896-163147897	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs549878828	chr6:163147919-163147920	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs140665427	chr6:163148000-163148001	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs535653923	chr6:163148011-163148012	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs373722165	chr6:163148031-163148032	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs548346449	chr6:163148032-163148033	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs11323412	chr6:163148033-163148034	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs554724761	chr6:163148051-163148052	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs73600002	chr6:163148080-163148081	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs372088893	chr6:163148114-163148115	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs191376895	chr6:163148118-163148119	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs375154977	chr6:163148127-163148128	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs368274732	chr6:163148163-163148164	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs61173844	chr6:163148166-163148167	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs577104809	chr6:163148189-163148190	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs371602451	chr6:163148265-163148266	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs563214378	chr6:163148283-163148284	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs547437305	chr6:163148316-163148317	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs531774976	chr6:163148318-163148319	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs13215897	chr6:163148344-163148345	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs561626668	chr6:163148353-163148354	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs527422896	chr6:163148355-163148356	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs554700169	chr6:163148368-163148369	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs547402532	chr6:163148563-163148564	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs114231735	chr6:163148583-163148584	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs528342807	chr6:163148586-163148587	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs532978581	chr6:163148590-163148591	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs550065161	chr6:163148605-163148606	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs540154030	chr6:163148609-163148610	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:434 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:163135600-163148200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr6:163137000-163148000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr6:163138400-163148000	Weak transcription	Aorta	Aorta
4	chr6:163140800-163147600	Weak transcription	HUES6 Cell Line	embryonic stem cell
5	chr6:163142600-163147600	Weak transcription	Skeletal Muscle Male	skeletal muscle
6	chr6:163142600-163147800	Weak transcription	Right Ventricle	heart
7	chr6:163143200-163147400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr6:163144200-163147600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr6:163144600-163147400	Weak transcription	Skeletal Muscle Female	skeletal muscle
10	chr6:163144600-163147600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
11	chr6:163144600-163147600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr6:163144600-163147600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
13	chr6:163144600-163147600	Weak transcription	Cortex derived primary cultured neurospheres	brain
14	chr6:163145400-163147400	Enhancers	Duodenum Mucosa	Duodenum
15	chr6:163146000-163147600	Weak transcription	Brain Substantia Nigra	brain
16	chr6:163146000-163149600	Enhancers	Stomach Mucosa	stomach
17	chr6:163146200-163147400	Weak transcription	Brain Angular Gyrus	brain
18	chr6:163146200-163147400	Weak transcription	Brain Anterior Caudate	brain
19	chr6:163146200-163147600	Weak transcription	Rectal Mucosa Donor 29	rectum
20	chr6:163146200-163147600	Weak transcription	Right Atrium	heart
21	chr6:163146200-163148000	Weak transcription	Pancreas	Pancrea
22	chr6:163146400-163147400	Weak transcription	Rectal Smooth Muscle	rectum
23	chr6:163146400-163147600	Enhancers	Liver	Liver
24	chr6:163146400-163147600	Weak transcription	Fetal Heart	heart
25	chr6:163146400-163147800	Weak transcription	Fetal Intestine Large	intestine
26	chr6:163146600-163147600	Weak transcription	Duodenum Smooth Muscle	Duodenum
27	chr6:163146600-163147600	Weak transcription	Rectal Mucosa Donor 31	rectum
28	chr6:163146600-163148000	Weak transcription	Left Ventricle	heart
29	chr6:163146600-163148200	Weak transcription	Gastric	stomach
30	chr6:163146800-163147600	Enhancers	Brain Inferior Temporal Lobe	brain
31	chr6:163146800-163147800	Weak transcription	Ovary	ovary
32	chr6:163146800-163147800	Weak transcription	Psoas Muscle	Psoas
33	chr6:163146800-163147800	Weak transcription	Small Intestine	intestine
34	chr6:163147000-163147600	Enhancers	Pancreatic Islets	Pancreatic Islet
35	chr6:163147200-163147800	Enhancers	Colon Smooth Muscle	Colon
36	chr6:163147200-163147800	Enhancers	Fetal Intestine Small	intestine
37	chr6:163147400-163147600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr6:163147400-163147600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr6:163147400-163147600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr6:163147400-163147600	Enhancers	Fetal Lung	lung
41	chr6:163147400-163147600	Active TSS	Skeletal Muscle Female	skeletal muscle
42	chr6:163147400-163147800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
43	chr6:163147400-163147800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
44	chr6:163147400-163147800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr6:163147400-163147800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr6:163147400-163147800	Enhancers	Brain Angular Gyrus	brain
47	chr6:163147400-163147800	Enhancers	Brain Anterior Caudate	brain
48	chr6:163147400-163147800	Enhancers	Fetal Kidney	kidney
49	chr6:163147400-163147800	Enhancers	Rectal Smooth Muscle	rectum
50	chr6:163147400-163148000	Flanking Active TSS	Duodenum Mucosa	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links